MB
Matthias Bodenstedt sold $862K of MLTX stock
Matthias Bodenstedt, Chief Financial Officer of MoonLake Immunotherapeutics (MLTX), sold 39,120 shares of MLTX stock worth $862K, per an SEC Form 4 filed Jun 23, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Jun 22, 2026, 1 day before it was made public.
MLTX has moved -43.3% since the trade date, from $22.16 to $12.56 (Nov 10, 2026 close).
- Traded
- Jun 22, 2026
- Disclosed
- Jun 23, 2026
- Filing delay
- 1 day
- Price since
- -43.3%
- Role
- Chief Financial Officer
- Source
- SEC Form 4